Effect of lymph node number on survival of patients with lymph node-negative gastric cancer according to the 7th edition UICC TNM system

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Xu, Dazhi ^a   Huang, Ying ^a   Geng, Qirong ^a   Guan, Yuanxiang ^a   Li, Yuanfang ^a   Wang, Wei ^a   Yuan, Shuqiang ^a   Sun, Xiaowei ^a   Chen, Yingbo ^a   Li, Wei ^a   Zhou, Zhiwei ^a   Zhan, Youqing ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; FEMALE; GASTRECTOMY; HEMATOLOGICAL PARAMETERS; HUMAN; LYMPH NODE COUNT; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PROPORTIONAL HAZARDS MODEL; STOMACH CANCER; TUMOR LOCALIZATION; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 84862559769     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038681     Document Type: Article

References (36)

1. Kamangar F, Dores GM, Anderson WF, (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities indifferent geographic regions of the world. J Clin Oncol 24: 2137-2150.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96.
3. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ, (2009) Gastric cancer. Lancet 374: 477-490.
4. Kim JP, Lee JH, Kim SJ, Yu HJ, Yang HK, (1998) Clinicopathologic characteristics and prognostic factors in 10783 patients with gastric cancer. Gastric Cancer 1: 125-133.
5. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 79: 1522-1530.
6. Kasakura Y, Mochizuki F, Wakabayashi K, Kochi M, Fujii M, (2002) An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: a retrospective study of 1403 cases at a single institution. J Surg Res 2002 103: 252-259.
7. Sobin LH, Gospodarowicz MK, Wittekind C, (2010) TNM classification of malignant tumours, 7th edition. 455 p.
8. Saito H, Kuroda H, Matsunaga T, Fukuda K, Tatebe S, (2010) Prognostic indicators in node-negative advanced gastric cancer patients. J Surg Oncol 101: 622-625.
9. Kajitani T, (1981) The general rules for the gastric cancer study in surgery and pathology: part I. Clinical classification. Jpn J Surg 11: 127-139.
10. Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, (2008) Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer 112: 1239-1246.
11. Xu DZ, Geng QR, Long ZJ, Zhan YQ, Li W, (2009) Positive lymph node ratio is an independent prognostic factor in gastric cancer after D2 resection regardless of the examined number of lymph nodes. Ann Surg Oncol 16: 319-326.
12. Wang W, Xu DZ, Li YF, Guan YX, Sun XW, (2011) Tumor-ratio-metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection-results of a single-institution study of 1343 Chinese patients. Ann Oncol 22: 2049-2056.
13. Xu DZ, (2010) The lymph node ratio staging system in gastric cancer. Ann Surg Oncol 17: 659.
14. Noda N, Sasako M, Yamaguchi N, Nakanishi Y, (1998) Ignoring small lymph nodes can be a major cause of staging error in gastric cancer. Br J Surg 85: 831-834.
15. Wong SL, Ji H, Hollenbeck BK, Morris AM, Baser O, (2007) Hospital lymph node examination rates and survival after resection for colon cancer. JAMA 298: 2149-2154.
16. Feinstein AR, Sosin DM, Wells CK, (1985) The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312: 1604-8.
17. Wu ZY, Li JH, Zhan WH, He YL, Wan J, (2007) Effect of lymph node micrometastases on prognosis of gastric carcinoma. World J Gastroenterol 13: 4122-4125.
18. Kim JH, Park JM, Jung CW, Park SS, Kim SJ, (2008) The significances of lymph node micrometastasis and its correlation with E-cadherin expression in pT1-T3N0 gastric adenocarcinoma. J Surg Oncol 97: 125-130.
19. Yasuda K, Adachi Y, Shiraishi N, Inomata M, Takeuchi H, (2002) Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer. Ann Surg Oncol 9: 771-774.
20. Baiocchi GL, Tiberio GA, Minicozzi AM, Morgagni P, Marrelli D, (2010) A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg 252: 70-73.
21. Siewert JR, (2005) Gastric cancer: the dispute between East and West. Gastric Cancer 8: 59-61.
22. Roviello F, Rossi S, Marrelli D, Pedrazzani C, Corso G, (2006) Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study. J Surg Oncol 94: 275-280.
23. Namikawa T, Kitagawa H, Iwabu J, Okabayashi T, Sugimoto T, (2010) Clinicopathological properties of the superficial spreading type early gastric cancer. J Gastrointest Surg 14: 52-57.
24. Bouvier AM, Haas O, Piard F, Roignot P, Bonithon-Kopp C, (2002) How Many Nodes Must Be Examined to Accurately Stage Gastric Carcinomas? Results from a population based study. Cancer 94: 2862-2866.
25. Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22: 2069-2077.
26. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 79: 1522-1530.
27. Ohtsu A, Yoshida S, Saijo N, (2006) Disparities in gastric cancer chemotherapy between the East and West. J Clin Oncol 24: 2188-2196.
28. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ, (2010) Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 11: 439-449.
29. Kooby DA, Suriawinata A, Klimstra DS, Brennan MF, Karpeh MS, (2003) Biologic predictors of survival in node-negative gastric cancer. Ann Surg 237: 828-835.
30. MacDonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345: 725-730.
31. Estes NC, MacDonald JS, Touijer K, Benedetti J, Jacobson J, (1998) Inadequate documentation and resection for gastric cancer in the United States: a preliminary report. Am Surg 64: 680-685.
32. Therneau TM, Grambsh PM, Flemming TR, (1990) Martingale based residuals for survival models. Biometrika 77: 147-160.
33. Yang HX, Xu Y, Fu JH, Wang JY, Lin P, (2010) An evaluation of the number of lymph nodes examined and survival for node-negative esophageal carcinoma: data from China. Ann Surg Oncol 17: 1901-1911.
34. Grambsch PM, Therneau TM, Fleming TR, (1995) Diagnostic plots to reveal functional form for covariates in multiplicative intensity models. Biometrics 51: 1469-1482.
35. Wijnhoven BP, Tran KT, Esterman A, Watson DI, Tilanus HW, (2007) An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg 245: 717-725.
36. Huang B, Zheng X, Wang Z, Wang M, Dong Y, (2009) Prognostic significance of the number of metastatic lymph nodes: is UICC/TNM node classification perfectly suitable for early gastric cancer? Ann Surg Oncol 16: 61-67.